GlassScriptPhysician profile
Marc A Kaufman
NPI 1740393339
$327.07
in general payments reported to CMS, 2019-2025
11 companies · $46.06 in 2025
The $46.06 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.62 · 2020: $38.18 · 2022: $54.73 · 2023: $51.13 · 2024: $88.35 · 2025: $46.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $100.62 | 2023-2025 | Intrarosa, Femring |
| Abbott Laboratories | $48.56 | 2022-2024 | Mitraclip |
| Amag Pharmaceuticals, INC. | $28.09 | 2019 | |
| Hologic Sales and Service, LLC | $27.42 | 2025 | Fluent Fluid Management System |
| Therapeuticsmd, INC. | $23.16 | 2020 | |
| Vertical Pharmaceuticals, LLC | $20.53 | 2019 | |
| Gynesonics, INC. | $19.18 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Allotrope Medical, INC | $17.22 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.02 | 2020 | |
| Mayne Pharma Commercial LLC | $13.95 | 2022 | |
| Shield Therapeutics INC | $13.32 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.